Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Retinal Blood Flow in Response to an Intravitreal Injection of Ranibizumab for Central Retinal Vein Occlusion

NCT01303276 is registered in ClinicalTrials.gov with University of Toronto as lead sponsor.

NCT NCT01303276
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01303276 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Retinal Blood Flow in Response to an Intravitreal Injection of Ranibizumab for Central Retinal Vein Occlusion
Lead sponsor
University of Toronto
Phase
Observational
Overall status
Unknown status
Start date
June 30, 2011
Completion date
Not reported
Enrollment
30 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

central retinal vein occlusion